Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescents.
Go back to Resource Center
Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescents.
Authors:
Secondary:
Volume:
Pagination:
Issue:
Journal:
PMID:
Keywords:
Abstract: